Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Famar Buys Bayer’s Quebec Plant | Contract Pharma

What are you searching for?

Sign in
Breaking News

Famar Buys Bayer’s Quebec Plant

Acquisition establishes the CMO’s North American presence

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Famar has unveiled plans to acquire the Pointe-Claire, Quebec, manufacturing site from Bayer’s consumer health division.

The Greece-based contract manufacturing organization (CMO) has a network of 11 sites in Europe, which supply a wide range of products to the industry, serving most international markets, with a broad customer base.

The company says the acquisition is an important step in its strategic growth plan. It is the first site Famar will operate in North America. With its FDA approval status, Pointe-Claire serves markets in both the U.S. and Canada.

Famar expects to close the transaction in early 2017, at which time the company is expected to have two FDA approved sites in their global network, the other one being in Europe.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics